HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 217 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $217,496 | -47.9% | 7,209 | -42.0% | 0.00% | -100.0% |
| Q1 2024 | $417,433 | -67.5% | 12,431 | -68.7% | 0.00% | -50.0% |
| Q4 2023 | $1,283,053 | +6929.3% | 39,723 | +7031.6% | 0.00% | – |
| Q3 2023 | $18,253 | -99.3% | 557 | -98.9% | 0.00% | -100.0% |
| Q4 2022 | $2,797,923 | +151.8% | 50,779 | +122.4% | 0.02% | +66.7% |
| Q1 2022 | $1,111,000 | +134.9% | 22,830 | +74.6% | 0.01% | +28.6% |
| Q4 2020 | $473,000 | +111.2% | 13,072 | +97.9% | 0.01% | +133.3% |
| Q3 2020 | $224,000 | – | 6,607 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $545,757,000 | 83.25% |
| Nan Fung Group Holdings Ltd | 768,708 | $37,398,000 | 17.74% |
| venBio Partners LLC | 1,544,484 | $75,139,000 | 16.66% |
| Vivo Capital, LLC | 4,570,148 | $222,338,000 | 15.31% |
| HealthInvest Partners AB | 120,000 | $5,838,000 | 9.30% |
| Aisling Capital Management LP | 342,815 | $16,678,000 | 9.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 205,474 | $20,533,000 | 4.63% |
| ASHFORD CAPITAL MANAGEMENT INC | 659,873 | $32,103,000 | 3.46% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $14,595,000 | 2.92% |
| Newlight Partners LP | 651,372 | $31,689,000 | 2.15% |